A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge - Wikidata - wikimedia - TriplyDB

A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge

A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge

http://www.wikidata.org/entity/Q35531454

about

Animal models for SARS and MERS coronaviruses Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies Middle East respiratory syndrome: obstacles and prospects for vaccine development Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease Animal models of Middle East respiratory syndrome coronavirus infection A decade after SARS: strategies for controlling emerging coronaviruses Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.Receptor-binding domain as a target for developing SARS vaccines.A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate.Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments.Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease.Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.SARS-like WIV1-CoV poised for human emergence.Middle East respiratory syndrome vaccines.Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques.Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.T cell-mediated immune response to respiratory coronaviruses.Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis.Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant.Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.MERS Vaccine Candidate Offers Promise, but Questions Remain.Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis.Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice

P2860

Q26799857-63AC3053-778E-46BE-AFF1-8DB4E0A48740 Q27011643-0B7002F6-258D-45BE-8211-601D25839C4F Q27013314-7F2786CB-3D71-4AF9-A1AC-70FDCFB7CAEA Q27683898-A9B2DD7A-D532-411B-8E9F-16A344B472AE Q28086778-5051496A-4149-4757-AF4D-F900D0DF095F Q28817689-842B7F4F-DBB3-4CAC-A860-FBD54161FDD2 Q30218075-76BE660D-DA79-4838-BEB5-40A718EB39ED Q30353170-F5060A0F-A95A-49DE-BF2F-5047326CB037 Q30360627-3323A945-8F56-43D8-9A31-4B459C21A126 Q30401512-BC6B9685-8D7A-4F97-8D75-1BB6AFD1FF53 Q34057901-A6E78281-A692-4FF1-92C8-797AF52DFD89 Q34247261-13A18845-F651-4D8D-AE66-5E97ACCF8E89 Q34309830-7B66E687-A355-43A9-A1C8-F43340CA678B Q34663663-ED8D5322-7BAA-45D5-84EC-86E0C8554EC8 Q35111000-F39564CC-7858-4006-96F2-E852087EB030 Q35660187-3AE771AA-D9CB-4CF5-A3F3-B57C8CCF5A0C Q36456720-7C4AD065-A773-479B-B9F4-04FC2A385128 Q36650501-C2F8E722-E0D8-4098-99D7-EDD182B65985 Q36702376-59B90A87-E910-46DC-8431-0655E5BF90C2 Q36710396-7825D3CB-34A2-44D7-B757-2FEC4E4453CB Q37143501-6595D6E5-DF27-4D02-A7E8-1C7642D64895 Q37169882-5AF36775-89B3-45E5-89A3-7D98AFE876EC Q37264927-49039C9D-7DBA-4F5A-9B38-CDA377A2E91B Q37635133-1B04D456-CE1F-41AF-A9AA-79156CCB418F Q37706472-33733E9A-8F17-42C3-80AB-03E3AFA52041 Q37713866-E19C5678-3B2A-417F-B833-3F80B2CEB8AD Q38156536-E0800986-1BDE-4BF9-848E-5A1563EC1A6B Q38213199-B33B9FBF-300B-4B34-874F-08F0F0EA7D3D Q38619800-5FDCC97F-E23A-4E58-96AC-75B72A9A6680 Q38638572-BC24B1A1-E5F6-4938-A6D9-F9B49B085D9A Q38992327-BB8B0610-2884-4EAD-9EA0-80A48B8EB3B9 Q40707492-8F89A676-E153-4D12-BCF9-8C6DCF0B97ED Q40715781-1C4BC4EF-DC23-4C77-8431-2C52DFA816EC Q40744757-F785FA93-0A44-4CD6-83E6-8788D8E936E2 Q40886051-8137CC95-DCE6-4F30-A47D-7B8DE4C5C28A Q47107616-42D3528D-B9DE-43E8-825C-5B02EAD2DD40 Q51783750-E6DDDBFE-718C-4DE1-B992-14837B27A6CC Q54241763-FA567EDF-D913-41F9-8636-C1249F368A29 Q56781312-9D21D98C-15F2-44FC-BACD-806F7B287A19 Q57094095-56E0C733-163E-49B6-907B-D547AB80FEEC

P2860

A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge

http://www.wikidata.org/entity/Q35531454

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A double-inactivated severe ac ...... monary response upon challenge

@ast

A double-inactivated severe ac ...... monary response upon challenge

@en

type

label

A double-inactivated severe ac ...... monary response upon challenge

@ast

A double-inactivated severe ac ...... monary response upon challenge

@en

prefLabel

A double-inactivated severe ac ...... monary response upon challenge

@ast

A double-inactivated severe ac ...... monary response upon challenge

@en

P1433

Q35531454-DBB7CE46-0A9F-4F11-8FC9-DCA58BBBBAC4

P1476

Q35531454-BEB7C4CA-17BA-4E12-9B8B-8EA602AE4095

P2093

Q35531454-25EC33D1-8D36-4336-8CDF-A2E8D7E37343

Q35531454-32039810-21A6-4DE2-AA16-B020772C6A4F

Q35531454-3F09D8F3-E742-4EC2-A7E7-D94A16A73FBD

Q35531454-4D656A16-70D4-4465-9495-80A8B361634F

Q35531454-546AF8BF-C317-4813-BBBC-672996FB8E4D

Q35531454-795B736F-04AE-4261-AB6C-24EB198A6C33

Q35531454-799EF319-2B83-435F-949A-F224607EBDB0

Q35531454-CA90DCAF-8380-42AB-B531-562A5C916C27

P2860

Q35531454-017D7D3D-38C1-4BCB-8591-EEEC9F7686B1

Q35531454-01D3A24B-3DB0-459E-99F7-948CC1C1DDDA

Q35531454-081F37A7-DBE6-413B-96B9-E19A65DAAE67

Q35531454-08E0645A-1D79-43B6-9683-E97B3D70DCB8

Q35531454-08F6623E-DD3B-4FC1-897D-3FFF47964152

Q35531454-0C1CAF82-E6E1-4E41-BE58-13A3B20DA9C4

Q35531454-140AD477-6D41-4AA7-A342-F4D88A771062

Q35531454-1BC89390-0BB7-413F-8807-8BC571A413F1

Q35531454-1D47D5F3-D3D9-439E-9D33-7E603CED4BCC

Q35531454-1D9D1DA1-CE3C-4115-AB62-D4DED51BBF36

P304

Q35531454-D7848E91-2968-4C5B-9576-C183C5F61F23

P31

Q35531454-9A4D6E37-7B56-4E0C-B1D5-DBE0282B9880

P356

Q35531454-09BB7FAE-41CC-46EF-A55A-C45AD291D870

P407

Q35531454-F46AA136-1440-4F7B-8812-6F6F98DE292C

P433

Q35531454-C48CC1F2-FDC8-4638-9A63-D3784FE0108C

P478

Q35531454-4C0AC077-008E-4BE9-8E94-1ECF89F7127E

P50

Q35531454-1918D13D-BE6F-4961-A998-E09AF39DFBA0

Q35531454-3EA0CF92-5D2A-4F58-A727-A1B557E0C746

Q35531454-AC1A811B-642D-48B5-A400-54170395FBC4

P577

Q35531454-EFA21312-24FF-43A3-82A0-CD38A3255F02

P698

Q35531454-5BF0D4EF-B95B-4549-9B20-19DE12541491

P932

Q35531454-07C00D96-6557-47BE-A53A-E6C7FCC0EAD2

P356

P1433

Journal of Virology

P1476

A double-inactivated severe ac ...... monary response upon challenge

@en

P2093

Alan Whitmore

http://www.w3.org/2001/XMLSchema#string

Allison Totura

http://www.w3.org/2001/XMLSchema#string

Damon Deming

http://www.w3.org/2001/XMLSchema#string

Kristin Long

http://www.w3.org/2001/XMLSchema#string

Lisa Gralinski

http://www.w3.org/2001/XMLSchema#string

Martin Ferris

http://www.w3.org/2001/XMLSchema#string

Sudhakar Agnihothram

http://www.w3.org/2001/XMLSchema#string

William Funkhouser

http://www.w3.org/2001/XMLSchema#string

P2860

SARS: systematic review of treatment effects

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge

Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection

Bats are natural reservoirs of SARS-like coronaviruses

Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants

Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine

B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.

A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

P304

12201-12215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.06048-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21937658

http://www.w3.org/2001/XMLSchema#string

P932

3209347

http://www.w3.org/2001/XMLSchema#string